Implantica Current Valuation vs. Current Ratio
| IMP-A-SDB | SEK 35.05 1.40 3.84% |
For Implantica profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Implantica to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Implantica AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Implantica's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Implantica AG over time as well as its relative position and ranking within its peers.
Implantica |
Implantica AG Current Ratio vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Implantica's current stock value. Our valuation model uses many indicators to compare Implantica value to that of its competitors to determine the firm's financial worth. Implantica AG is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in current ratio category among its peers . The ratio of Current Valuation to Current Ratio for Implantica AG is about 100,994,133 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Implantica's earnings, one of the primary drivers of an investment's value.Implantica Current Valuation vs. Competition
Implantica AG is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is currently estimated at about 291.09 Billion. Implantica claims roughly 5.38 Billion in current valuation contributing just under 2% to all equities under Medical Devices industry.
Implantica Current Ratio vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Implantica |
| = | 5.38 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Implantica |
| = | 53.28 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Implantica Current Ratio Comparison
Implantica is currently under evaluation in current ratio category among its peers.
Implantica Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Implantica, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Implantica will eventually generate negative long term returns. The profitability progress is the general direction of Implantica's change in net profit over the period of time. It can combine multiple indicators of Implantica, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden.
Implantica Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Implantica. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Implantica position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Implantica's important profitability drivers and their relationship over time.
Use Implantica in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Implantica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Implantica will appreciate offsetting losses from the drop in the long position's value.Implantica Pair Trading
Implantica AG Pair Trading Analysis
The ability to find closely correlated positions to Implantica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Implantica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Implantica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Implantica AG to buy it.
The correlation of Implantica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Implantica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Implantica AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Implantica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Implantica position
In addition to having Implantica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Soft Drinks Thematic Idea Now
Soft Drinks
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.